Sponsor:
Corcept Therapeutics
Code:
NCT06947304
Conditions
Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Non-alcoholic Fatty Liver Disease (NAFLD)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Miricorilant
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-16. This information was provided to ClinicalTrials.gov by Corcept Therapeutics on 2025-08-14.